Risk Communication panel inception

FDA will convene the first meeting of its new Risk Communication Advisory Committee Feb. 28 to discuss the agency's risk communication programs and regulatory responsibilities. The committee is charged with advising FDA on methods to effectively communicate the risks associated with all products, including those that emerge after a product is on the market. On Feb. 29, the panel will advise FDA on best risk-communication practices for the agency's proposed template for press releases announcing product recalls. The advisory panel was established in response to a recommendation by the Institute of Medicine as part of its evaluation of the U.S. drug safety system (1"The Pink Sheet" Nov. 12, 2007, p. 8)...